SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Non-Tech : Kirk's Market Thoughts
COHR 177.38+3.8%Dec 4 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: wilywilly who wrote (13132)2/20/2022 7:51:56 PM
From: Kirk ©1 Recommendation

Recommended By
rdkflorida2

  Read Replies (1) of 26687
 
Fascinating, especially the part where they said ivermectin might be beneficial in parts of the world where parasite infection is common and that causes dangerous side effects so eliminating the parasites with ivermectin could be what makes people have better survival rates there.

Clearly we know many who have taken ivermectin prophylactically who still got COVID and the recent study shows no magic benefit for taking it after being hospitalized. Maybe there is a middle ground that the current studies will prove or disprove.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News